We serve Chemical Name:4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine CAS:53461-40-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine
CAS.NO:53461-40-8
Synonyms:4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine
Molecular Formula:C9H12ClN3
Molecular Weight:197.66500
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:342.5ºC at 760 mmHg
Density:1.245g/cm3
Index of Refraction:1.574
PSA:29.02000
Exact Mass:197.07200
LogP:2.10360
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine Use and application,4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine technical grade,usp/ep/jp grade.
Related News: In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. 4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine manufacturer In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. 4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine supplier The Branchburg factory first came under FDA scrutiny in late 2019, when agency inspectors began to document numerous quality control problems. By March, 2020, the FDA had deemed the manufacturing issues as “Official Action Indicated,” its most serious category of violation. 4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine vendor When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant. 4-chloro-6-methyl-2-pyrrolidin-1-ylpyrimidine factory The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry.
